Stay updated with breaking news from Systemic Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this fourth episode of OncChats: Reviewing Best Practices in the Surgical Management of Breast Cancer, Gladys Giron, MD, FACS, and Cristina Lopez-Peñalver, MD, discuss how to appropriately manage patients with stage IV breast cancer and outline when surgical approaches may be appropriate for this population.
Dr Linda Stein Gold discusses the shift in the treatment paradigm in plaque psoriasis.
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass., October 13, 2023--BeiGene (Nasdaq: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending approval of BRUKINSA® (zanubrutinib), a Bruton’s tyrosine kinase inhibitor (BTKi), in combination with obinutuzumab for the treatment of adult patients with relapsed or refractory (R/R) follicul
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
Analysis of 1,025 recently switched PsA patients reveals second- or later-line usage of IL-17, IL-23, and JAK inhibitors growing in popularity....